Foresite Capital

VC San Francisco, United States · Founded 2011

Website

Foresite Capital is a multi-stage healthcare and life sciences investment firm that uses a data science-driven approach to fund promising businesses across all stages of their life cycles. They invest in companies that leverage biology and big data to transform healthcare, focusing on breakthrough opportunities at the intersection of technology and biotechnology. [9, 13, 14]

About Foresite Capital

Foresite Capital is a healthcare-dedicated multi-stage investment firm with substantial assets under management, investing across drug development, medical devices, diagnostics, and healthcare technology including digital health and AI. The foresitecapital.com website confirms a healthcare-specialist platform with funds spanning early venture through public market crossover investing. For healthcare AI founders, Foresite is one of the more credible specialists in the market: the team brings deep biology and clinical expertise, and the firm has the capital scale to lead Series B and C rounds and follow on through IPO. Plausible check sizes range from 5M at early venture to 50M plus in growth and crossover rounds. Founders building therapeutics, diagnostics, medical devices, or AI-native life sciences platforms with strong scientific founders and credible clinical or regulatory paths should approach. Founders building digital health workflow SaaS or telehealth services without a strong life sciences differentiator may find the fit thinner; Foresite’s edge is in regulated, science-heavy businesses. Entry path is warm introduction through life sciences operator networks, biotech executive contacts, or other healthcare specialist VCs in their syndicate networks. The firm participates in Cowen, JPMorgan Healthcare, and Biotech Showcase conferences; conference introductions work for founders with credible scientific stories. Diligence is technically rigorous: expect deep engagement with your scientific advisory board, IP review, regulatory strategy assessment, and clinical milestone scrutiny. Foresite’s value-add includes downstream capital, public market expertise, and strategic relationships with pharma, which is a serious advantage for businesses building toward acquisition or IPO. Bring your scientific co-founder to the first meeting and lead with the science.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Share your experience

At a glance

Type VC

Stages Growth, Series A, Series B, Series C, Series D+

Check size $25M+

Sub-verticals AI/ML in Healthcare, Biotech, Diagnostics

HQ San Francisco, United States

Founded 2011

Visit website

Healthcare AI tools backed by Foresite Capital

Tools made by companies in Foresite Capital's portfolio that we cover in the directory.

Natera Genetic Testing

Natera

Lab & Diagnostics

Natera is a global leader in cell-free DNA testing, offering AI-driven genetic testing and analysis in oncology, women's health, organ health, and rare diseases. Physicians can order tests and receive comprehensive reports for diagnostic and treatment planning, leveraging Natera's clinically validated and regulatory-compliant solutions.

Natera offers various pricing options including insurance coverage, prompt-pay cash prices, and financial assistance programs. they are in-network with most national and regional healthcare plans, including medicare. patients can receive pre-test cost estimates.

Cancer Copilot

Color Health

Oncology AI

Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.